I get the feeling a few of the larger holders might share...

I get the feeling a few of the larger holders might share somewhat similar sentiments Wegian. I'm sure most would have an average price of 20c+, this doesn't provide a heap of incentive to sell out.

I'd like to see what the independent William Buck analysis comes back with. Personally would be hoping for a revision upwards in the offer. Given the offer is only 11.7m AUD (or 9.2m USD), I know ICU has the ability to to add a bit extra on to sweeten the pot having seen their recent 2nd Q results...

http://ir.icumed.com/news-releases/...cal-inc-announces-second-quarter-2017-results


Whilst I see the tie in and ICU is a company with great prospects and a bright future, the benefits at this point lie squarely in the ICU camp, not LT holders of MLA.